About Us

Columbia Laboratories to Discuss First Quarter 2013 Financial Results on May 9 Conference Call

Columbia Laboratories Inc. (Nasdaq: CBRX) will hold a conference call on May 9, 2013, to discuss financial results of the first quarter ended March 31, 2013. Frank Condella, President and Chief Executive Officer, and Jonathan Lloyd Jones, Vice President and Chief Financial Officer of Columbia Laboratories, will host the call.

Date: Thursday, May 9, 2013
Time: 11:00 am Eastern Time
Dial-in numbers: (877) 303-9483 (U.S. & Canada) or (760) 666-3584
Conference ID: 52824557
Live webcast:

www.columbialabs.com under the 'Investors' tab

The teleconference replay will be available two hours after completion through Thursday, May 16, 2013, at (855) 859-2056 (U.S. & Canada) or (404) 537-3406. The conference ID for the replay is 52824557. The archived webcast will be available for one year on the Company's website, www.columbialabs.com, in the 'Investors' section under 'Events'.

About Columbia Laboratories

Columbia Laboratories, Inc. is a specialty pharmaceutical company with a successful history of developing proprietary, vaginally administered products for women’s health indications. For more information, please visit www.columbialabs.com.

Contacts:

Columbia Laboratories, Inc.
Jonathan Lloyd Jones, 973-486-8818
Vice President & CFO
or
The Trout Group LLC
Seth Lewis, 646-378-2952
Senior Vice President

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.